Moderna secures up to $50 million to develop an Ebola vaccine.

The Global Coronavirus Vaccine Market sees growth opportunities driven by the need for updated vaccines against new viral variants, ongoing R&D for pan-coronavirus vaccines, non-injectable ...

By Jennifer Rigby, Mariam Sunny and Siddhi Mahatole June 1 (Reuters) - Global health organisation CEPI will give roughly $60 million to Moderna and two other groups to accelerate the development of ...

Seventy-five countries have submitted expressions of interest to protect their populations and those of other nations through joining the COVAX Facility, a mechanism designed to guarantee rapid, fair ...

Read Coronavirus vaccine latest news on The Economic Times. When will coronavirus vaccine be available in India? Coronavirus ...

Get the latest news stories and videos on the Coronavirus with trackers on vaccines, hospitalizations, and deaths.

Vaccine hesitancy has become more emotionally charged and politically fraught, many physicians say, and more and more parents ...

Learn about the companies that are manufacturing vaccines and what you should know before investing in vaccine stocks.

East Africa’s Ebola outbreak, driven by the rare Bundibugyo strain, has no approved vaccine or treatment, prompting urgent ...

The first known case challenges the notion that the pandemic erupted suddenly. Instead, several peer-reviewed studies ...